Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Cardiac Effects of Phentermine

Primary Cardiac Effects

  • Phentermine is a sympathomimetic amine that works by increasing norepinephrine levels in the central nervous system, which can affect cardiovascular function 3
  • Potential for blood pressure elevation, though observational data from phentermine monotherapy shows minimal significant increases in blood pressure in most treated individuals 2
  • Small increases in heart rate may occur, particularly at higher doses 2

Serious Cardiovascular Concerns

Valvular Heart Disease

  • The historical association with valvular heart disease was primarily linked to the combination of fenfluramine-phentermine ("fen-phen"), with fenfluramine being the primary culprit 3
  • Fenfluramine metabolites directly activated serotonin receptors (5-hydroxytryptamine type 2B) in cardiac tissues 3, 4

Clinical Monitoring and Contraindications

  • Blood pressure and heart rate should be monitored periodically during phentermine treatment 2, 5
  • Phentermine is contraindicated in patients with:
    • History of cardiovascular disease 2, 3
    • Uncontrolled hypertension 2, 5
    • Patients taking monoamine oxidase inhibitors (or within 14 days of discontinuation) due to risk of hypertensive crisis 2

Long-term Cardiovascular Safety

  • There are currently no large cardiovascular outcome trial data for long-term use of phentermine monotherapy 2
  • Phentermine is FDA-approved only for short-term use (≤12 weeks), though many clinicians use it off-label for longer periods 2, 5

Special Considerations

  • Consider starting at lower doses (as low as 4-8 mg) in patients with cardiac risk factors 2
  • Phentermine should be taken earlier in the day to minimize insomnia 2

Practical Recommendations

  • Prior to initiating phentermine, conduct a thorough cardiovascular risk assessment 2
  • Start with the lowest effective dose in patients with any cardiac risk factors 2
  • Monitor blood pressure and heart rate at baseline and periodically during treatment 2, 5